Service-Based Survey of Dystonia in MunichCastelon Konkiewitz E.a · Trender-Gerhard I.a · Kamm C.b · Warner T.c · Ben-Shlomo Y.c · Gasser T.b · Conrad B.a · Ceballos-Baumann A.O.a
Departments of aNeurology, Klinikum rechts der Isar, Technische Universität München, and bNeurology, Klinikum Grosshadern, Ludwig-Maximilians Universität München, Munich, Germany, and cThe Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
We performed a service-based epidemiological study of dystonia in Munich, Germany. Due to favourable referral and treatment patterns in the Munich area, we could provide confident data from dystonia patients seeking botulinum toxin treatment. A total of 230 patients were ascertained, of whom 188 had primary dystonia. Point prevalence ratios were estimated to be 10.1 (95% confidence interval 8.4–11.9) per 100,000 for focal and 0.3 (0.0–0.6) for generalised primary dystonia. The most common focal primary dystonias were cervical dystonia with 5.4 (4.2–6.7) and essential blepharospasm with 3.1 (2.1–4.1) per 100,000 followed by laryngeal dystonia (spasmodic dysphonia) with 1.0 (0.4–1.5) per 100,000.
© 2002 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.